Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and other bioactive molecules. Its protected amine (CBZ) and ester functionalities allow for selective transformations in multi-step organic syntheses. Commonly employed in the preparation of neuroactive compounds and antiviral agents due to its structural compatibility with peptidomimetic frameworks. The compound’s stereochemistry enables high enantioselectivity in final drug candidates, making it valuable in medicinal chemistry for optimizing potency and reducing off-target effects.